Similar articles

• Validation of a new fluorogenic real-time PCR assay for detection of CYP2C9 allelic variants and CYP2C9 allelic distribution in a German population.

  Burian M, Grösch S, Tegeder I, Geisslinger G. Burian M, et al. Br J Clin Pharmacol. 2002 Nov;54(5):518-21. doi: 10.1046/j.1365-2125.2002.01693.x. Br J Clin Pharmacol. 2002. PMID: 12445031 Free PMC article.
• A simple method for the detection of CYP2C9 polymorphisms: nested allele-specific multiplex polymerase chain reaction.

  Zainuddin Z, Teh LK, Suhaimi AW, Salleh MZ, Ismail R. Zainuddin Z, et al. Clin Chim Acta. 2003 Oct;336(1-2):97-102. doi: 10.1016/s0009-8981(03)00319-x. Clin Chim Acta. 2003. PMID: 14500040
• SYBR Green-based real-time PCR assay for detection of VKORC1 and CYP2C9 polymorphisms that modulate warfarin dose requirement.

  Huang SW, Li Q, Zhu SY, Li L, Xiong F, Jia YK, Xu XM. Huang SW, et al. Clin Chem Lab Med. 2009;47(1):26-31. doi: 10.1515/CCLM.2009.008. Clin Chem Lab Med. 2009. PMID: 19117406
• Allele and genotype frequencies of CYP2C9 within an Iranian population (Mazandaran).

  Hashemi-Soteh SM, Shahabi-Majd N, Gholizadeh AR, Shiran MR. Hashemi-Soteh SM, et al. Genet Test Mol Biomarkers. 2012 Jul;16(7):817-21. doi: 10.1089/gtmb.2011.0301. Epub 2012 Jan 30. Genet Test Mol Biomarkers. 2012. PMID: 22288731 Clinical Trial.
• Genotyping for CYP2C9 and VKORC1 alleles by a novel point of care assay with HyBeacon® probes.

  Howard R, Leathart JB, French DJ, Krishan E, Kohnke H, Wadelius M, van Schie R, Verhoef T, Maitland-van der Zee AH, Daly AK, Barallon R. Howard R, et al. Clin Chim Acta. 2011 Nov 20;412(23-24):2063-9. doi: 10.1016/j.cca.2011.07.013. Epub 2011 Jul 29. Clin Chim Acta. 2011. PMID: 21827742